Barbolina and colleagues were able to demonstrate that downregulation of CX3CR1 leads to reduced peritoneal metastasis, and increased receptor expression in human ovarian cancer was associated with a worsened prognosis [10]. The gene discussed is CX3CR1; the disease is ovarian carcinoma.